MARKER THERAPEUTICS (MRKR) Competitors $1.58 +0.01 (+0.38%) As of 07/3/2025 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MRKR vs. MNOV, ADAP, ANRO, CLSD, BMEA, RENB, ANEB, VHAQ, IMMX, and ACHLShould you be buying MARKER THERAPEUTICS stock or one of its competitors? The main competitors of MARKER THERAPEUTICS include MediciNova (MNOV), Adaptimmune Therapeutics (ADAP), Alto Neuroscience (ANRO), Clearside Biomedical (CLSD), Biomea Fusion (BMEA), Renovaro (RENB), Anebulo Pharmaceuticals (ANEB), Viveon Health Acquisition (VHAQ), Immix Biopharma (IMMX), and Achilles Therapeutics (ACHL). These companies are all part of the "pharmaceutical products" industry. MARKER THERAPEUTICS vs. Its Competitors MediciNova Adaptimmune Therapeutics Alto Neuroscience Clearside Biomedical Biomea Fusion Renovaro Anebulo Pharmaceuticals Viveon Health Acquisition Immix Biopharma Achilles Therapeutics MARKER THERAPEUTICS (NASDAQ:MRKR) and MediciNova (NASDAQ:MNOV) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends. Which has stronger earnings & valuation, MRKR or MNOV? MARKER THERAPEUTICS has higher revenue and earnings than MediciNova. MediciNova is trading at a lower price-to-earnings ratio than MARKER THERAPEUTICS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMARKER THERAPEUTICS$6.59M2.70-$10.73M-$1.33-1.18MediciNova$1M61.80-$11.04M-$0.23-5.48 Is MRKR or MNOV more profitable? MediciNova has a net margin of 0.00% compared to MARKER THERAPEUTICS's net margin of -224.46%. MediciNova's return on equity of -20.77% beat MARKER THERAPEUTICS's return on equity.Company Net Margins Return on Equity Return on Assets MARKER THERAPEUTICS-224.46% -101.87% -83.02% MediciNova N/A -20.77%-19.68% Do insiders and institutionals believe in MRKR or MNOV? 22.4% of MARKER THERAPEUTICS shares are held by institutional investors. Comparatively, 9.9% of MediciNova shares are held by institutional investors. 14.5% of MARKER THERAPEUTICS shares are held by insiders. Comparatively, 13.6% of MediciNova shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, MRKR or MNOV? MARKER THERAPEUTICS has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, MediciNova has a beta of 0.4, meaning that its share price is 60% less volatile than the S&P 500. Does the media refer more to MRKR or MNOV? In the previous week, MARKER THERAPEUTICS's average media sentiment score of 0.00 equaled MediciNova'saverage media sentiment score. Company Overall Sentiment MARKER THERAPEUTICS Neutral MediciNova Neutral Do analysts prefer MRKR or MNOV? MARKER THERAPEUTICS currently has a consensus target price of $13.17, indicating a potential upside of 735.45%. MediciNova has a consensus target price of $7.00, indicating a potential upside of 455.56%. Given MARKER THERAPEUTICS's higher probable upside, equities research analysts clearly believe MARKER THERAPEUTICS is more favorable than MediciNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MARKER THERAPEUTICS 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50MediciNova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryMARKER THERAPEUTICS beats MediciNova on 8 of the 13 factors compared between the two stocks. Get MARKER THERAPEUTICS News Delivered to You Automatically Sign up to receive the latest news and ratings for MRKR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRKR vs. The Competition Export to ExcelMetricMARKER THERAPEUTICSMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.10M$2.42B$5.50B$9.01BDividend YieldN/A1.77%5.38%4.04%P/E RatioN/A9.1027.6020.30Price / Sales2.70490.15368.81103.83Price / CashN/A157.0736.6357.47Price / Book0.914.638.055.68Net Income-$10.73M$31.34M$3.18B$249.13M7 Day Performance7.95%3.25%2.82%3.30%1 Month Performance4.37%6.80%3.70%5.20%1 Year Performance-69.63%1.89%35.41%21.38% MARKER THERAPEUTICS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRKRMARKER THERAPEUTICS3.2435 of 5 stars$1.58+0.4%$13.17+735.4%-69.6%$18.10M$6.59M0.0060MNOVMediciNova1.891 of 5 stars$1.31+1.6%$7.00+434.4%-10.0%$64.26M$1M-5.7010Gap DownADAPAdaptimmune Therapeutics2.3281 of 5 stars$0.24-4.2%$1.52+526.4%-75.4%$64.25M$178.03M-0.90490ANROAlto Neuroscience2.4435 of 5 stars$2.37+5.1%$8.50+259.4%-79.8%$64.02MN/A-1.01N/ACLSDClearside Biomedical1.4545 of 5 stars$0.82-2.3%$4.80+485.1%-34.2%$63.75M$1.66M-2.0030BMEABiomea Fusion2.7704 of 5 stars$1.69-6.6%$21.40+1,166.3%-62.0%$63.49MN/A-0.4850RENBRenovaro1.1893 of 5 stars$0.37+7.9%N/A-82.4%$63.38MN/A-0.4820Gap UpHigh Trading VolumeANEBAnebulo Pharmaceuticals2.2536 of 5 stars$1.52-1.3%$5.50+261.8%-29.0%$62.44MN/A-5.854VHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumeIMMXImmix Biopharma3.1952 of 5 stars$2.23-0.4%$7.00+213.9%+4.3%$62.17MN/A-3.199Gap UpACHLAchilles TherapeuticsN/A$1.48flatN/AN/A$60.83MN/A-0.90250 Related Companies and Tools Related Companies MediciNova Alternatives Adaptimmune Therapeutics Alternatives Alto Neuroscience Alternatives Clearside Biomedical Alternatives Biomea Fusion Alternatives Renovaro Alternatives Anebulo Pharmaceuticals Alternatives Viveon Health Acquisition Alternatives Immix Biopharma Alternatives Achilles Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRKR) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MARKER THERAPEUTICS, INC. Please log in to your account or sign up in order to add this asset to your watchlist. Share MARKER THERAPEUTICS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRKR Stock Alerts